Johnson & Johnson (JNJ) delivered mixed results in FY2026 on revenue of $99.1B versus the $99.9B estimate (+20.2% YoY) and EPS of $1.59. Below is the full Johnson & Johnson earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Johnson & Johnson (JNJ) Earnings Analysis — key stats
Latest reported quarter
FY2026
Earnings verdict
Mixed
Revenue
$99.1B (vs $99.9B est · -0.8% surprise · +20.2% YoY)
EPS
$1.59 (vs $1.66 est · -4.2% surprise · +23.9% YoY)
Share price
$407.40 (+3.9%)
Market cap
$2.31T
What you'll find
Next Johnson & Johnson (JNJ) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Johnson & Johnson reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Johnson & Johnson (JNJ)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Johnson & Johnson's next earnings date?
Magnisto tracks Johnson & Johnson's (JNJ) earnings schedule and shows the confirmed next earnings date, the options-implied expected move and the estimates analysts are modeling into the print.
Did Johnson & Johnson (JNJ) beat or miss earnings?
In FY2026, Johnson & Johnson (JNJ) posted mixed results — revenue of $99.1B versus the $99.9B estimate (-0.8% surprise) and EPS of $1.59 versus $1.66 expected (-4.2% surprise). Magnisto decodes every Johnson & Johnson (JNJ) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Johnson & Johnson (JNJ) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Johnson & Johnson (JNJ), anchored to the current $407.40 share price, so you can weigh the bull, base and bear cases for Johnson & Johnson side by side.
Is Johnson & Johnson (JNJ) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Johnson & Johnson fits your own thesis and risk profile. This is research, not investment advice.